Comparison of the antidepressant sertraline on differential depression-like behaviors elicited by restraint stress and repeated corticosterone administration

Pharmacology Biochemistry and Behavior

Volumn 97, Issue 2, 2010, Pages 213-221

  Ulloa, J L ^a   Castaneda P ^a   Berrios C ^a   Diaz Veliz G ^b   Mora, S ^b   Bravo, J A ^a,c   Araneda, K ^a   Menares, C ^a   Morales, P ^b   Fiedler, J L ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Antidepressant; Anxiety; Behavior; Corticosterone; Depression; Restraint; Sertraline; Stress

Indexed keywords

CORTICOSTERONE; SERTRALINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; AVOIDANCE BEHAVIOR; BEHAVIOR CHANGE; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; ESCAPE BEHAVIOR; FORCED SWIMMING TEST; IMMOBILIZATION STRESS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADRENAL GLANDS; ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANXIETY; AVOIDANCE LEARNING; CONDITIONING, OPERANT; CORTICOSTERONE; DEPRESSION; MALE; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RESTRAINT, PHYSICAL; SERTRALINE; STRESS, PSYCHOLOGICAL; SWIMMING; WEIGHT GAIN;

ANIMALIA; RATTUS;

EID: 77957774843     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.08.001     Document Type: Article

References (71)

1. Ardayfio P., Kim K.S. Anxiogenic-like effect of chronic corticosterone in the light-dark emergence task in mice. Behav Neurosci 2006, 120:249-256.
2. Austin M.P., Mitchell P., Goodwin G.M. Cognitive deficits in depression: possible implications for functional neuropathology. Br J Psychiatry 2001, 178:200-206.
3. Bambico F.R., Nguyen N.T., Gobbi G. Decline in serotonergic firing activity and desensitization of 5-HT1A autoreceptors after chronic unpredictable stress. Eur Neuropsychopharmacol 2009, 19:215-228.
4. Bondi C.O., Rodriguez G., Gould G.G., Frazer A., Morilak D.A. Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment. Neuropsychopharmacol 2008, 33:320-331.
5. Bravo J.A., Diaz-Veliz G., Mora S., Ulloa J.L., Berthoud V.M., Morales P., et al. Desipramine prevents stress-induced changes in depressive-like behavior and hippocampal markers of neuroprotection. Behav Pharmacol 2009, 20:273-285.
6. Brown E.S., Varghese F.P., McEwen B.S. Association of depression with medical illness: does cortisol play a role?. Biol Psychiatry 2004, 55:1-9.
7. Brown E.S., Rush A.J., McEwen B.S. Hippocampal remodeling and damage by corticosteroids: implications for mood disorders. Neuropsychopharmacology 1999, 21:474-484.
8. Brown S.M., Henning S., Wellman C.L. Mild, short-term stress alters dendritic morphology in rat medial prefrontal cortex. Cereb Cortex 2005, 15:1714-1722.
9. Caspi A., Sugdin K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., McClay J., Mill J., Martin J., Braithwaite A., Poulton R. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003, 301:386-389.
10. Cipriani A., La Ferla T., Furukawa T.A., Signoretti A., Nakagawa A., Churchill R., McGuire H., Barbui C. Sertraline versus other antidepressive agents for depression. Cochrane Database Syst Rev. 2010, CD006117.
11. Cole M.A., Kalman B.A., Pace T.W., Topczewski F., Lowrey M.J., Spencer R.L. Selective blockade of the mineralocorticoid receptor impairs hypothalamic-pituitary-adrenal axis expression of habituation. J Neuroendocrinol 2000, 12:1034-42.
12. Cryan J.F., Holmes A. The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discov 2005, 4:775-790.
13. Cryan J.F., Markou A., Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 2002, 23:238-245.
14. Cryan J.F., Valentino R.J., Lucki I. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev 2005, 29:547-569.
15. Cyr M., Charbonneau C., Morissette M., Rochford J., Barden N., Di Paolo T. Central 5-hydroxytryptamine-2A receptor expression in transgenic mice bearing a glucocorticoid receptor antisense. Neuroendocrinology 2001, 73:37-45.
16. David D.J., Samuels B.A., Rainer Q., Wang J.W., Marsteller D., Mendez I., et al. Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 2009, 62:479-493.
17. Deakin J.F. 5HT2 receptors, depression and anxiety. Pharmacol Biochem Behav 1988, 29:819-820.
18. de Kloet E.R., Oitzl M.S., Joels M. Stress and cognition: are corticosteroids good or bad guys?. Trends Neurosci 1999, 22:422-426.
19. Detke M.J., Johnson J., Lucki I. Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression. Exp Clin Psychopharmacol 1997, 5:107-112.
20. Deuschle M., Schweiger U., Weber B., Gotthardt U., Korner A., Schmider J., Standhardt H., Lammers C.H., Heuser I. Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls. J Clin Endocrinol Metab 1997, 82:234-238.
21. Detke M.J., Rickels M., Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl) 1995, 121:66-72.
22. Dhabhar F.S., McEwen B.S., Spencer R.L. Adaptation to prolonged or repeated stress - comparison between rat strains showing intrinsic differences in reactivity to acute stress. Neuroendocrinology 1997, 65:360-368.
23. Fernandes C., McKittrick C.R., File S.E., McEwen B.S. Decreased 5-HT1A and increased 5-HT2A receptor binding after chronic corticosterone associated with a behavioural indication of depression but not anxiety. Psychoneuroendocrinology 1997, 22:477-491.
24. Fiedler JL, Bravo J, Ulloa JL. What are the possible consequences of chronic stress in central nevous system? In: Aboitiz F, Dagnino-Subiabre A, editors. The Neurobiology of Stress: An Evolutionary Approach. Kerala: Research Signpost, 2007, p 79-118.
25. Filipenko M.L., Beilina A.G., Alekseyenko O.V., Dolgov V.V., Kudryavtseva N.N. Repeated experience of social defeats increases serotonin transporter and monoamine oxidase A mRNA levels in raphe nuclei of male mice. Neurosci Lett 2002, 321:25-28.
26. Gadek-Michalska A., Bugajski J. Repeated handling, restraint, or chronic crowding impair the hypothalamic-pituitary-adrenocortical response to acute restraint stress. J Physiol Pharmacol 2003, 54:449-459.
27. Gartside S.E., Leitch M.M., Young A.H. Altered glucocorticoid rhythm attenuates the ability of a chronic SSRI to elevate forebrain 5-HT: implications for the treatment of depression. Neuropsychopharmacology 2003, 28:1572-1578.
28. Girotti M., Pace T.W., Gaylord R.I., Rubin B.A., Herman J.P., Spencer R.L. Habituation to repeated restraint stress is associated with lack of stress-induced c-Fos expression in primary sensory processing areas of the rat brain. Neuroscience 2006, 138:1067-1081.
29. Gourley S.L., Kiraly D.D., Howell J.L., Olausson P., Taylor J.R. Acute hippocampal brain-derived neurotrophic factor restores motivational and forced swim performance after corticosterone. Biol Psychiatry 2008, 64:884-890.
30. Gourley S.L., Taylor J.R. Recapitulation and reversal of a persistent depression-like syndrome in rodents. Curr Protoc Neurosci 2009, Chapter 9:Unit 9:32.
31. Gourley S.L., Wu F.J., Kiraly D.D., Ploski J.E., Kedves A.T., Duman R.S., Taylor J.R. Regionally specific regulation of ERK MAP kinase in a model of antidepressant-sensitive chronic depression. Biol Psychiatry 2008, 63:353-359.
32. Gregus A., Wintink A.J., Davis A.C., Kalynchuk L.E. Effect of repeated corticosterone injections and restraint stress on anxiety and depression-like behavior in male rats. Behav Brain Res 2005, 156:105-114.
33. Grippo A.J., Sullivan N.R., Damjanoska K.J., Crane J.W., Carrasco G.A., Shi J., et al. Chronic mild stress induces behavioral and physiological changes, and may alter serotonin 1A receptor function, in male and cycling female rats. Psychopharmacology (Berl) 2005, 179:769-780.
34. Hinkelmann K., Moritz S., Botzenhardt J., Riedesel K., Wiedemann K., Kellner M., Otte C. Cognitive impairment in major depression: association with salivary cortisol. Biol Psychiatry 2009, 66:879-885.
35. Joels M., Pu Z., Wiegert O., Oitzl M.S., Krugers H.J. Learning under stress: how does it work?. Trends Cogn Sci 2006, 10:152-158.
36. Johnson S.A., Fournier N.M., Kalynchuk L.E. Effect of different doses of corticosterone on depression-like behavior and HPA axis responses to a novel stressor. Behav Brain Res 2006, 168:280-288.
37. Kalynchuk L.E., Gregus A., Boudreau D., Perrot-Sinal T.S. Corticosterone increases depression-like behavior, with some effects on predator odor-induced defensive behavior, in male and female rats. Behav Neurosci 2004, 118:1365-1377.
38. Karten Y.J., Nair S.M., van Essen L., Sibug R., Joels M. Long-term exposure to high corticosterone levels attenuates serotonin responses in rat hippocampal CA1 neurons. Proc Natl Acad Sci USA 1999, 96:13456-13461.
39. Kim J.J., Haller J. Glucocorticoid hyper- and hypofunction: stress effects on cognition and aggression. Ann N Y Acad Sci 2007, 1113:291-303.
40. Lecrubier Y. The burden of depression and anxiety in general medicine. J Clin Psychiatry 2001, 62 Suppl 8:4-9.
41. Lesch K.P. Gene-environment interaction and the genetics of depression. J Psychiatry Neurosci 2004, 29:174-184.
42. Lucassen P.J., Vollmann-Honsdorf G.K., Gleisberg M., Czeh B., De Kloet E.R., Fuchs E. Chronic psychosocial stress differentially affects apoptosis in hippocampal subregions and cortex of the adult tree shrew. Eur J Neurosci 2001, 14:161-166.
43. Lucki I. The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav Pharmacol 1997, 8:523-532.
44. Magarinos A.M., McEwen B.S., Flugge G, Fuchs E. Chronic psychosocial stress causes apical dendritic atrophy of hippocampal CA3 pyramidal neurons in subordinate tree shrews. J Neurosci 1996, 16:3534-3540.
45. Maj J., Moryl E. Effects of sertraline and citalopram given repeatedly on the responsiveness of 5-HT receptor subpopulations. J Neural Transm Gen Sect 1992, 88:143-156.
46. Marks W., Fournier N.M., Kalynchuk L.E. Repeated exposure to corticosterone increases depression-like behavior in two different versions of the forced swim test without altering nonspecific locomotor activity or muscle strength. Physiol Behav 2009, 98:67-72.
47. Melia K.R., Ryabinin A.E., Schroeder R., Bloom F.E., Wilson M.C. Induction and habituation of immediate early gene expression in rat brain by acute and repeated restraint stress. J Neurosci 1994, 14:5929-5938.
48. Millan M.J. Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs. Neurotherapeutics 2009, 6:53-77.
49. Mineka S., Zinbarg R. A contemporary learning theory perspective on the etiology of anxiety disorders: it's not what you thought it was. Am Psychol 2006, 61:10-26.
50. Mora, S, Díaz-Véliz, G. Intracerebral administration of neuropeptides: an assessment of behavioral change. In: Conn, M, editor. Paradigms for the study of behavior. Methods in neurosciences. San Diego, CA: Academic Press, 1993, p 180-93.
51. Murray F., Smith D.W., Hutson P.H. Chronic low dose corticosterone exposure decreased hippocampal cell proliferation, volume and induced anxiety and depression like behaviours in mice. Eur J Pharmacol 2008, 583:115-127.
52. Murray, CJL, Lopez, AD, Harvard School of Public Health, World Health Organization, World Bank. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge, MA: Published by the Harvard School of Public Health on behalf of the World Health Organization and the World Bank; Distributed by Harvard University Press, 1996.
53. Nasr S.J., Gibbons R.D. Depressive symptoms associated with dexamethasone resistance. Psychiatry Res 1983, 10:183-189.
54. Nestler E.J., Gould E., Manji H., Buncan M., Duman R.S., Greshenfeld H.K., Hen R., Koester S., Lederhendler I., Meaney M., Robbins T., Winsky L., Zalcman S. Preclinical models: status of basic research in depression. Biol Psychiatry 2002, 52:503-528.
55. Pariante C.M., Miller A.H. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry 2001, 49:391-404.
56. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985, 14:149-167.
57. Pepin M.C., Govindan M.V., Barden N. Increased glucocorticoid receptor gene promoter activity after antidepressant treatment. Mol Pharmacol 1992, 41:1016-1022.
58. Pepin M.C., Pothier F., Barden N. Antidepressant drug action in a transgenic mouse model of the endocrine changes seen in depression. Mol Pharmacol 1992, 42:991-995.
59. Pittenger C., Duman R.S. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 2008, 33:88-109.
60. Porsolt R.D., Le Pichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977, 266:730-732.
61. Reneric J.P., Lucki I. Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test. Psychopharmacology (Berl) 1998, 136:190-197.
62. Sheline Y.I. Hippocampal atrophy in major depression: a result of depression-induced neurotoxicity?. Mol Psychiatry 1996, 1:298-299.
63. Sheline Y.I., Sanghavi M., Mintun M.A., Gado M.H. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 1999, 19:5034-5043.
64. Tafet G.E., Idoyaga-Vargas V.P., Abulafia D.P., Calandria J.M., Roffman S.S., Chiovetta A., et al. Correlation between cortisol level and serotonin uptake in patients with chronic stress and depression. Cogn Affect Behav Neurosci 2001, 1:388-393.
65. Tafet G.E., Toister-Achituv M., Shinitzky M. Enhancement of serotonin uptake by cortisol: a possible link between stress and depression. Cogn Affect Behav Neurosci 2001, 1:96-104.
66. Ulrich-Lai Y.M, Herman J.P. Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci 2009, 10:397-409.
67. Viau V., Sawchenko P.E. Hypophysiotropic neurons of the paraventricular nucleus respond in spatially, temporally, and phenotypically differentiated manners to acute vs. repeated restraint stress: rapid publication. J Comp Neurol 2002, 445:293-307.
68. Walf A.A., Frye C.A. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc 2007, 2:322-328.
69. Wong M.L., Kling M.A., Munson P.J., Listwak S., Licinio J., Prolo P., Karp B., McCutcheon I.E., Geracioti T.D.Jr., DeBellis M.D., Rice K.C., Goldstein D.S., Veldhuis J.D., Chrousos G.P., Oldfield E.H., McCann S.M., Gold P.W. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci USA 2000, 97:325-330.
70. Young A.H., Sahakian B.J., Robbins T.W., Cowen P.J. The effects of chronic administration of hydrocortisone on cognitive function in normal male volunteers. Psychopharmacology (Berl) 1999, 145:260-266.
71. Zhao Z., Zhang H.T., Bootzin E., Millan M.J., O'Donnell J.M. Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs. Neuropsychopharmacology 2008, 34:1467-1481.